ClinicalTrials HQ

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Recruiting · NCT05703971 · Registry updated 2026-09-11
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC PatientsSmall Cell Lung Cancer Extensive StageRecruitingPhase 1 / Phase 22026-09-11NCT05703971

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Genprex, Inc.2

17 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Gabrail Cancer Center ResearchCantonUnited States26
Northwest Cancer Specialists, P.C.PortlandUnited States2
Northwest Cancer Specialists, P.C.VancouverUnited States12
Northwest Cancer Specialists, P.C.TigardUnited States9
Northwest Cancer Specialists, P.C.PortlandUnited States9
Oncology_Hematology Care Clinical Trials, LLCFairfieldUnited States1
Oncology_Hematology Care Clinical Trials, LLCCincinnatiUnited States1
Oncology_Hematology Care Clinical Trials, LLCCincinnatiUnited States1
Oncology_Hematology Care Clinical Trials, LLCCincinnatiUnited States1
Oncology_Hematology Care Clinical Trials, LLCCincinnatiUnited States1
Providence Cancer InstitutePortlandUnited States17
Rocky Mountain Cancer Centers, LLPLone TreeUnited States11
Texas Oncology - DFWDallasUnited States19
Texas Oncology - Northeast TexasTylerUnited States18
Virginia Cancer Specialists, PCFairfaxUnited States35
Washington University School of Medicine - Siteman Cancer CenterSt LouisUnited States19
Willamette Valley Cancer Institute (Oregon)EugeneUnited States1